MARZINZIK; Andreas

Patent Applications and Registrations

Patent applications and USPTO patent grants for MARZINZIK; Andreas.The latest application filed is for "cyclic peptides as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorders".

Company Profile

0.14.26

MARZINZIK; Andreas - Weil am Rhein DE
MARZINZIK; Andreas - Weil DE
MARZINZIK; Andreas - Basel CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclic Peptides As Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Inhibitors For The Treatment Of Metabolic Disorders App 20220024981 - FLYER; Alec Nathanson ; et al.	2022-01-27
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20180134695 - FURET; Pascal ; et al.	2018-05-17
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,896,444 - Furet , et al. February 20, 2	2018-02-20
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,458,112 - Furet , et al. October 4, 2	2016-10-04
Benzamide Derivatives For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20160200705 - FURET; Pascal ; et al.	2016-07-14
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20160185733 - FURET; Pascal ; et al.	2016-06-30
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,340,537 - Furet , et al. May 17, 2	2016-05-17
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,315,489 - Furet , et al. April 19, 2	2016-04-19
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,278,981 - Furet , et al. March 8, 2	2016-03-08
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20150183801 - Furet; Pascal ; et al.	2015-07-02
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20150141427 - Furet; Pascal ; et al.	2015-05-21
Benzamide Derivatives For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20150126485 - Furet; Pascal ; et al.	2015-05-07
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20140343086 - DODD; Stephanie Kay ; et al.	2014-11-20
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 8,829,195 - Dodd , et al. September 9, 2	2014-09-09
Compounds And Compositions For Inhibiting The Activity Of Abl1, Abl2 And Bcr-abl1 App 20130310395 - DODD; Stephanie Kay ; et al.	2013-11-21
Biphenyl Substituted 1,3-dihydro-benzoimidazol-2-ylideneamine Derivatives App 20130090342 - Berst; Frederic ; et al.	2013-04-11
Piperidinyl Substituted 1,3-dihydro-benzoimidazol-2-ylideneamine Derivatives App 20130085161 - Berst; Frederic ; et al.	2013-04-04
Kallikrein 7 Modulators App 20130028843 - FLOHR; Stefanie ; et al.	2013-01-31
Kallikrein 7 modulators Grant 8,309,596 - Flohr , et al. November 13, 2	2012-11-13
Organic compounds Grant 8,163,773 - Breitenstein , et al. April 24, 2	2012-04-24
Quinolines As Inhibitors Of Farnesyl Pyrophosphate Synthase App 20120094958 - Amstutz; Rene ; et al.	2012-04-19
Salicylic Acid Derivatives Being Farnesyl Pyrophosphate Synthase Activity Inhibitors App 20110288057 - Cotesta; Simona ; et al.	2011-11-24
Organic Compounds App 20090233920 - Breitenstein; Werner ; et al.	2009-09-17
Organic Compounds App 20080242698 - Flor; Peter Josef ; et al.	2008-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.